Diagnostic Study of Tumor Characteristics in Patients With Ewing's Sarcoma

Completed

Conditions studied: Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

In brief

Diagnostic trial to study genetic differences in patients who have Ewing's sarcoma. Genetic testing may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy.

Key facts

Study ID

NCT00048984

Run by

Children's Oncology Group

People needed

637

Starts

2003-01-01

Last updated by the study team

2013-06-24

Who can join

Age: any, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed or recurrent Ewing's sarcoma
• Availability of the following specimens:
• Paraffin-embedded block or 20 unstained slides and 1-3 thick (50 micron) sections from initial biopsy
• Pretreatment serum and whole blood
• Concurrent therapy is not required

Where it is running

• Children's Oncology Group — Arcadia, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.